AMPH vs. NVO
Compare and contrast key facts about Amphastar Pharmaceuticals, Inc. (AMPH) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMPH or NVO.
Key characteristics
| AMPH | NVO | |
|---|---|---|
| YTD Return | -33.40% | 27.86% |
| 1Y Return | -33.19% | 63.54% |
| 3Y Return (Ann) | 25.53% | 44.11% |
| 5Y Return (Ann) | 15.93% | 41.91% |
| 10Y Return (Ann) | 16.49% | 20.82% |
| Sharpe Ratio | -0.76 | 1.96 |
| Daily Std Dev | 42.13% | 32.60% |
| Max Drawdown | -49.92% | -51.38% |
| Current Drawdown | -36.63% | -10.42% |
Fundamentals
| AMPH | NVO | |
|---|---|---|
| Market Cap | $2.00B | $593.01B |
| EPS | $2.91 | $2.91 |
| PE Ratio | 14.07 | 45.32 |
| PEG Ratio | 2.77 | 2.36 |
| Total Revenue (TTM) | $530.50M | $189.94B |
| Gross Profit (TTM) | $289.26M | $160.30B |
| EBITDA (TTM) | $202.42M | $96.60B |
Correlation
The correlation between AMPH and NVO is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AMPH vs. NVO - Performance Comparison
In the year-to-date period, AMPH achieves a -33.40% return, which is significantly lower than NVO's 27.86% return. Over the past 10 years, AMPH has underperformed NVO with an annualized return of 16.49%, while NVO has yielded a comparatively higher 20.82% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMPH vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AMPH vs. NVO - Dividend Comparison
AMPH has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 0.74%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMPH Amphastar Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 0.74% | 0.71% | 0.84% | 0.94% | 1.33% | 1.51% | 1.97% | 1.52% | 2.87% | 0.92% | 1.43% | 1.23% |
Drawdowns
AMPH vs. NVO - Drawdown Comparison
The maximum AMPH drawdown since its inception was -49.92%, roughly equal to the maximum NVO drawdown of -51.38%. Use the drawdown chart below to compare losses from any high point for AMPH and NVO. For additional features, visit the drawdowns tool.
Volatility
AMPH vs. NVO - Volatility Comparison
The current volatility for Amphastar Pharmaceuticals, Inc. (AMPH) is 9.01%, while Novo Nordisk A/S (NVO) has a volatility of 9.49%. This indicates that AMPH experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AMPH vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities